tiprankstipranks
Trending News
More News >
Immuron Ltd (IMRN)
NASDAQ:IMRN

Immuron (IMRN) Similar Stocks

Compare
207 Followers

Comparison Results

Name
Price
Market Cap
P/E Ratio
Yearly Gain
Analyst Consensus
Analyst Price Target
Top Analysts' Price Target
Smart Score
Follow
Immuron
$1.02
$8.44M
-1.74
-51.43%
0 Buy
0 Hold
0 Sell
Hold
Can-Fite BioPharma
$0.28
$24.37M
-81.32%
1 Buy
0 Hold
0 Sell
Moderate Buy
Lipocine
$2.92
$17.60M
-3.12
-36.47%
2 Buy
0 Hold
0 Sell
Moderate Buy
Adaptimmune Therapeutics
$0.06
-95.06%
BioVie
$1.45
$10.93M
-0.16
-94.29%
0 Buy
0 Hold
0 Sell
Moderate Buy
Aspire Biopharma Holdings
$0.10
$13.15M
-0.06
-99.17%

Performance Comparison

Ticker
Company Name
Price
Change
% Change
IMRN
Immuron
1.02
-1.08
-51.43%
CANF
Can-Fite BioPharma
0.28
-1.23
-81.46%
LPCN
Lipocine
3.17
-1.82
-36.47%
ADAP
Adaptimmune Therapeutics
0.04
-0.55
-93.22%
BIVI
BioVie
1.45
-23.95
-94.29%
ASBP
Aspire Biopharma Holdings
0.10
-11.35
-99.13%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts